About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, August 28th, 2012

The QualityStocks
Daily Stock List

graphic
graphic

Optibase Ltd. (OBAS)

Street Insider and SmarTrend Newsletters reported this month on Optibase Ltd. (OBAS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Global Market, Optibase Ltd. invests in the fixed-income real estate field. Currently, the Company holds properties in Rümlang and Geneva, Switzerland, and Miami, Florida. Optibase is currently looking for additional real estate investment opportunities. Optibase previously engaged in the field of digital video technologies until the sale of their video solutions business to Optibase Technologies Ltd., a wholly owned subsidiary of VITEC Multimedia in July of 2010.

Founded in 1990, Optibase has their headquarters in Herzliya, Israel. In March of 1999, the Company had an Initial Public Offering (IPO). This was followed by a secondary offering in March of 2000. The Company purchases and operates real estate properties for the purpose of commercial, industrial, office space, parking garage, and warehouse use, as well as for residential purposes.

Mr. Amir Philips is the Chief Executive Officer (CEO) of Optibase. He was appointed CEO in June 2011. From May 2007, Mr. Philips served as the CFO of Optibase. Prior to this position, Mr. Philips served as Vice President Finance of Optibase, Inc. - positions he held from July 2004.

This month, Optibase announced financial results for the second quarter ended June 30, 2012. Revenues from fixed income real estate totaled $3.4 million for the quarter ended June 30, 2012. This is in comparison to revenues of $3.8 million for the second quarter of 2011 and $3.5 million for the first quarter of 2012. Net loss for the second quarter ended June 30, 2012 was $289,000 or $0.02 per basic and diluted share. This is in comparison to a net loss of $113,000 or $0.01 per basic and diluted share for the second quarter of 2011 and to a net income of $904,000 or $0.05 per basic and diluted share for the first quarter of 2012.

For the six months ended June 30, 2012, net income was $615,000 or $0.03 per basic and diluted share. This is compared to a net income of $1.1 million or $0.07 per basic and diluted share for the six months ended June 30, 2011. As of June 30, 2012, Optibase had cash, cash equivalents, restricted cash and other financial investments, net, of $25.9 million, and shareholders' equity of $62.3 million, compared with $25.8 million, and $64.6 million, respectively, as of March 31, 2012.

Optibase Ltd. (OBAS), closed on Tuesday at $1.12, up 10.89%, on 17,060 volume with 6 trades. The average volume for the last 60 days is 2,156 and the stock's 52-week low/high is $0.0621/$1.54.

Resverlogix Corp. (RVX.TO)

Stockhouse and Super Stock Picker reported previously on Resverlogix Corp. (RVX.TO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Resverlogix Corp. is a clinical stage cardiovascular company whose shares trade on the Toronto Stock Exchange. The Company has an epigenetic platform technology that modulates protein production. Resverlogix is developing RVX-208, a first-in-class small molecule for the treatment of atherosclerosis. Resverlogix’ Business Model is to look for strategic opportunities through early alliance partnerships that are best suited to bring their technology platforms to successful commercialization. The Company is based in Calgary, Alberta.

The NexVas™ Plaque Regression program is Resverlogix’ primary focus. This focus is to develop novel small molecules that enhance ApoA-I production. These vital therapies are focused to address the burden of atherosclerosis and other important diseases such as Acute Coronary Syndrome, Alzheimer's disease, Peripheral Artery Disease and Autoimmune diseases.

The Company’s RVX-208 is the first BET bromodomain inhibitor in clinical trials. New compounds arising from Resverlogix' epigenetic drug discovery platform function by inhibiting BET bromodomains. RVX-208 is currently in clinical study for the treatment of atherosclerosis. RVX-208 functions by removing atherosclerotic plaque through reverse cholesterol transport (RCT). This is the natural process through which atherosclerotic plaque is transported out of the arteries and removed from the body by the liver.

RVX-208 increases production of ApoA-I, the key building block of functional high-density lipoprotein (HDL) particles and the type required for RCT. RVX-208 is currently undergoing evaluation in phase 2b studies for its ability to reverse and/or stabilize atherosclerotic disease.

Today, Resverlogix announced that the BET protein inhibitor RVX-208 significantly increased HDL-C (p=0.001), the primary endpoint of the SUSTAIN trial, a phase 2b clinical study. SUSTAIN also successfully met secondary endpoints, showed increases in levels of Apo-AI (p=0.002) and large HDL particles (p=0.02), both believed to be important factors in enhancing reverse cholesterol transport activity. The SUSTAIN trial also showed that increases in alanine aminotransferase (ALT) reported in previous trials were infrequent and transient with no new increases observed beyond week 12 of the 24-week trial.

The phase 2b SUSTAIN trial took place in South Africa and was led by investigators at the Cleveland Clinic. The study enrolled 176 patients with established atherosclerotic cardiovascular disease (CVD) and low high-density cholesterol (HDL-C).

Resverlogix Corp. (RVX.TO), closed on Tuesday at $1.75, up 11.46%, on 304,011 volume. The average volume for the last 60 days is 30,616 and the stock's 52-week low/high is $1.01/$2.30.

Diamond Frank Exploration, Inc. (DOD.V)

We are highlighting Diamond Frank Exploration, Inc.(DOD.V), here at the QualityStocks Daily Newsletter.

Founded in 2007, Diamond Frank Exploration, Inc. is a Canadian based mineral exploration company. The Company’s specialty is the search for metals and minerals deposits in areas of Quebec. Diamond Frank Exploration owns five properties, 100 percent-owned or in partnership. The Company’s shares trade on the TSX Venture Exchange. Diamond Frank has their corporate headquarters in Laval, Quebec.

The Commandant Property is located approximately 70 km south of the town of Val d'Or, in the Le Barroys Township. It consists of 64 confirmed mining claims (cells) and covers 3,717 hectares. The Commandant Extension property is located approximately 50 km south of Val d’Or, in the Le Baroys Township. It consists of 102 mining claims located to the north and west of the Company’s Commandant Property. The Commandant Extension covers a total surface of 5,920 hectares.

The Destorbelle Property is located approximately 25 km northeast of the town of Rouyn-Noranda. The property consists of 24 contiguous mining claims, located at the junction of the Destor, Cléricy and Aiguebelle townships. The Destorbelle Property covers an area of 953.1 hectares.

The Gold Peak Property is approximately 35 km northeast of the town of Rouyn-Noranda, in the township of la Pause. The property consists of 50 contiguous mineral claims, covering a total area of 2,172 hectares. Diamond Frank Exploration’s K6 Property is located in the Otish Mountains area, northeast of Chibougamau. It consists of two claim blocks (cells) totaling 25 titles covering an area of ​​1322.4 hectares.

Earlier this month, Diamond Frank Exploration announced that the Company’s team is now awaiting analysis results from the drilling campaign carried out on the Commandant Project. In addition, Diamond Frank announced the appointment of Mr. Claude Lavoie as a new member of the Company's Board of Directors. Mr. Lavoie is a soldier by profession, working for the Government of Canada since 1983. He has completed a number of mandates internationally in Europe, Bosnia-Herzegovina, Africa and Afghanistan.

Diamond Frank Exploration, Inc. (DOD.V), closed on Tuesday at $0.035, up 16.67%, on 653,569 volume. The average volume for the last 60 days is 100,277 and the stock's 52-week low/high is $0.03/$0.13.

Newtek Business Services, Inc. (NEWT)

Wall Street Resources reported yesterday on Newtek Business Services, Inc. (NEWT), RedChip did last week, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Newtek Business Services, Inc., doing business as The Small Business Authority, distributes a range of business services and financial products to the small- and medium-sized business market in the U.S. The Small Business Authority is a brand of the Company. The establishment of the Small Business Authority brand has been to provide real-time, state of the art content and business services to become the destination for small-business owners all across America. Newtek Business Services is based in New York, New York.

The Small Business Authority’s mission is to provide the small-business community with the experts, services, technologies, and resources needed to succeed in today’s competitive and ever-changing marketplace. Their primary purpose is to help businesses grow revenues, reduce expenses, and minimize risks. The Small Business Authority’s Business Lending Division is a nonbank lender. They provide end-to-end financing solutions, specializing in helping businesses obtain needed funds. Their Merchant Processing Service provides a high-quality, customized program and pricing structure so businesses can accept noncash payments. The Small Business Authority’s Web Services include web design, internet marketing, and web hosting.

Newtek provides their services to more than 100,000 business accounts. The Company has positioned the Newtek™ brand as a one-stop-shop provider of business services. The Company provides an array of products and services including Electronic Payment Processing, Managed Technology Solutions (Cloud Computing), eCommerce, Business Lending, Insurance Services, Web Services, Data Backup, Storage and Retrieval, Accounts Receivable Financing, and Payroll.

Recently, Newtek Business Services announced that they will be attending the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 11, 2012. Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions.

Mr. Barry Sloane, President and CEO of Newtek, will make a 25-minute presentation and host a one-on-one session with investors in order to gain visibility for Newtek Business Services. There are currently more than 20 companies set to present at the technology track and over 150 companies set to present overall.

Newtek Business Services, Inc. (NEWT), closed on Tuesday at $1.76, up 1.73%, on 39,715 volume with 66 trades. The average volume for the last 60 days is 52,952 and the stock's 52-week low/high is $1.00/$2.11.

Pristine Solutions, Inc. (PRTN)

WiseAlerts, SmallCapInvestorDaily, PennyStockScholar, Penny Trackers, AwesomePennyStocks, StockEgg, Titan Stocks, PennyStocksUniverse, Michael Stone, and OTCtipReporter reported on Pristine Solutions, Inc.(PRTN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pristine Solutions, Inc., by way of their wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3. This is a patent pending novel indication of an existing Food and Drug Administration (FDA) approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women. Pristine Solutions has their headquarters in Beverly Hills, California. The Company lists on the OTCQB.

Yesterday, Pristine Solutions announced that they completed the acquisition of Eaton Scientific Systems, a biomedical product development company focusing on women's health solutions. Eaton Scientific has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women. The drug indication, Tropine 3, is currently being prescribed and compounded by doctors in Los Angeles, California specifically for their patients who have hot flash symptoms and do not want to take hormonal treatment.

According to the 2000 U.S. Census, there are more than 37.5 million American women between the ages of 40-59 that are in the age range for pre-menopause, menopause and peri-menopause that have the potential for experiencing hot flash symptoms.

In addition, yesterday, Eaton Scientific Systems announced that they completed the acquisition of pending patent USPTO #60/719,756, an invention that provides a Method for Relieving Climacteric Symptoms (Hot Flashes). 

Mr. Michael Borkowski, Chief Executive Officer and President of Eaton Scientific, stated, "The Company believes that its Patent Pending Application covering a novel indication of the FDA approved drug homatropine, known as Tropine 3, has substantial strategic value in the rapidly growing women's healthcare market, particularly the menopausal symptom management market. Safe and effective non-hormonal menopausal symptom management is a very high priority issue for many women.  Eaton Scientific is well positioned to benefit from this dramatic global market opportunity, as the Company continues to develop market awareness and prepares to introduce Tropine 3 to a much larger audience in the near future."

Pristine Solutions, Inc. (PRTN), closed on Tuesday at $0.3850, up 5.19%, on 18,279,903 volume with 2,434 trades. The average volume for the last 60 days is 2,226,391 and the stock's 52-week low/high is $0.15/$0.53.

Bebida Beverage Co. (BBDA)

Wallstreetlivechat, Penny Stock Rumble, Stock Analyzer, Momentum Beats, and Greenbackers reported this month on Bebida Beverage Co. (BBDA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Bebida Beverage Co. is a developer, manufacturer and marketer of liquid relaxation products. These include KOMA Unwind "Liquid Relaxation" ™, KOMA Unwind Sugar-free "Liquid Relaxation" ™ and KOMA Unwind "Liquid Relaxation" Shot™. These also include Potencia Energy, Potencia "BLAST" energy shot, Relax 5 shots and Piranha Water. Bebida Beverage lists on the OTC Markets – Pink Current Information. The Company has their corporate headquarters in Statesville, North Carolina.

Bebida’s KOMA Unwind is a multi-berry flavor lightly carbonated beverage enhanced with the dietary supplements of Melatonin, Milk Thistle, Rose Hips and Valarium root. It is offered in regular and sugar free versions using Splenda as its sweetener. The Company’s RELAX 5 2 oz. shots have a special blend of supplements. Their Potencia is an energy drink that combines exotic natural flavors like Tamarind with special ingredients. The Potencia energy drink is the very first energy drink known, made of the very popular Tamarind fruit.

The Company’s Piranha Purified Water has been produced by distillation, de-ionization, reverse osmosis, or other suitable processes. Purified water may also be referred to as “demineralized water.” It meets the definition of “purified water” in the United States Pharmacopoeia.

Earlier this month, Bebida Beverage announced, in the Company's efforts to completely cover the nation from coast to coast with KOMA Unwind liquid relaxation, a partnership has been formed with Amagra, LLC. Amagra will distribute KOMA Unwind to a substantial area of northern California. This will include San Jose, the third largest city in California, with a population of 7.6 million people, Alameda County which includes the East Bay region with a population of more than 1.5 million people and the Sacramento area, the fourth largest population center in California. Combined, a population of almost 10 million people in northern California will have access to the liquid relaxation product.

In addition, Bebida Beverage announced this month that Mcleod, Inc. - Fun Drinks Distributing has come onboard to partner with Bebida Beverage to distribute the Company's flagship product, KOMA Unwind liquid relaxation to Philadelphia, Delaware and Bucks counties in Pennsylvania. This will now bring the product to more than 2 million people that the product was previously not widely available to.

Bebida Beverage Co. (BBDA), closed on Tuesday at $0.0135, up 14.41%, on 79,746,014 volume with 710 trades. The average volume for the last 60 days is 93,517,456 and the stock's 52-week low/high is $0.0003/$0.0199.

New America Energy Corp. (NECA)

Investor Spec Sheet, MajorPennyStocks, StockRunway, SmallCapVoice, StockGuru, and Bold Stocks reported earlier on New America Energy Corp. (NECA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

New America Energy Corp. is an exploration stage mineral exploration company with corporate headquarters in Las Vegas, Nevada. The Company was incorporated as Atheron, Inc. in the State of Nevada on May 8, 2006. On November 5, 2010 they underwent a change of control; on November 15, 2010 they changed their name to New America Energy Corp., and subsequently started looking for opportunities to acquire exploration stage oil and gas or mineral properties. New America Energy’s shares trade on the OTCBB.

On May 31, 2011, New America Energy entered into a property acquisition agreement with GeoXplor Corp. With the terms of the agreement the Company acquired an option, as well as exploration rights, in certain unpatented mining claims located in Clayton Valley, Nye County, Nevada. Thereafter, on October 27, 2011, they entered into an amended property acquisition agreement where they acquired additional claims. On June 20, 2012, the Company entered into an amended purchase agreement where they agreed to further amend and entirely replace the Amended Agreement with the new agreement, which modifies the consideration provided to GeoXplor by New America Energy for the Original and New Claims.

At present, the Company controls approximately 5,600 acres in Nevada. The Mud Lake lithium project property is nine miles southwest of Tonopah Nevada in the Ralston Valley. The Mud Lake property consists of twenty placer claims covering approximately 3,200 acres in Nye County.

New America Energy’s Clayton Ridge claims are strategically located adjacent to the Clayton Valley playa, on the southern extension of the Clayton Ridge Trough approximately five miles southeast of the Chemetall Foote lithium deposit. Chemetall-Foote Corp.'s Silver Peak operation, located in Clayton Valley, is the only lithium brine producer in North America and has been in operation since 1966. The Clayton Ridge trough has been defined by a number of gravity geophysical surveys. It is considered to be a major conduit for the lithium brines that have been leached from the lithium enriched Montezuma Peak rhyolitic tuffs and the lithium enriched waters of Alkali Hot Spring.

New America Energy Corp. (NECA), closed on Tuesday at $0.045, up 12.50%, on 25,600 volume with 3 trades. The average volume for the last 60 days is 17,196 and the stock's 52-week low/high is $0.0216/$0.60.

Vidable, Inc. (VIBE)

MomentumBeats reported last week on Vidable, Inc. (VIBE), Patti Sherwood, OTCPicks, PennyTrader Publisher, Greenbackers, HotShotStocks, Maryann Bronson, Dianne Foscarota did earlier, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Vidable, Inc. is a development stage online video classified company. They will connect merchants and customers by way of streaming video, mobile technology and social media. Previously, the Company was known as "The Blackhawk Fund". They engaged in the acquisition and development of real estate properties in the U.S. They still hold one property in their portfolio. Vidable’s intention is to operate a next-generation website that incorporates streaming video and mobile technology and uses various best- of-breed features. The Company has their headquarters in Carson City, Nevada.

Vidable will operate a centralized business Internet portal (an online classified website). This is to allow consumers to find information about a host of products and services through business and consumer posted videos.  The Company’s objectives for the next 12 months include development of a website with streaming video capability; growing their user base; establishing Vidable as a trusted resource for business transactions, as well as establishing a base in local markets before expanding across the nation.

In November 2011, Vidable entered into an Exclusive Software Property, Technical Information and Trade Mark License Agreement with Vidable AG. With this, they received the worldwide exclusive license to all of the software, technical information and trademarks necessary to commercialize the business of and allow customers to view a video instead of a static image when viewing potential items for purchase, rent and marketing their products.

In February 2012, the Company launched their online classified website in test market format in New York, New York. In May 2012, Vidable signed an Agreement with TL Media, a privately owned international media agency offering a total package of online media solutions. With this Agreement, TL Media will develop an online media campaign for Vidable with the intention of driving traffic to Vidable’s website in hopes of generating revenues and increased visibility for businesses advertising on the Vidable website.
In July 2012, Vidable announced their plan to sell Vidable licenses to allow third parties to sell Vidable digital media services under the Vidable brand for a monthly fee. The Company’s intention is to base part of their revenue model on selling banner ads. Over the next 12 months, their intention is to build out their management team, hire a sales force, site moderator and additional site developers.

Vidable, Inc. (VIBE), closed on Tuesday at $0.0055, even for the day, on 125,000 volume with 2 trades. The average volume for the last 60 days is 2,161,254 and the stock's 52-week low/high is $0.004/$0.60.

graphic

The QualityStocks
Company Corner

graphic
graphic

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.09, up 66.67%, on 623,000 volume with 10 trades. The stock’s average daily volume over the past 60 days is 68,406, and its 52-week low/high is $0.001/$0.018.

Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.

Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.

In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming

Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming

Consorteum Completes Acquisition of Tarsin Inc.

Skinny Nutritional Corp. (SKNY)

The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.01, even with yesterday's close, on 1,836,902 volume with 37 trades. The stock’s average daily volume over the past 60 days is 2,954,852, and its 52-week low/high is $0.005/$0.057.

Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.

The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.

The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.

Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer

Skinny Nutritional Corp. Blog

Skinny Nutritional Corp. News:

Skinny Nutritional Corp. to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+

A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration

Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally

MusclePharm Corp. (MSLP)

The QualityStocks Daily Newsletter would like to spotlight MusclePharm Corp. (MSLP). Today, MusclePharm Corp. closed trading at $0.01, even for the day, on 1,916,206 volume with 35 trades. The stock’s average daily volume over the past 60 days is 1,091,974, and its 52-week low/high is $0.0055/$0.0375.

MusclePharm Corp. (MSLP) is focused on providing a full line of Informed Choice-approved nutritional supplements that not use any substances banned in the sports industry. Now sold in more than 120 countries and available in over 10,000 U.S. retail outlets, the company's products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen.

Current CEO Brad Pyatt founded the company to develop a superior line of nutritional supplements that would help fellow athletes improve their performance in a way that existing supplements did not. Even as the company has grown, its mission has remained the same: to improve its customers' lives, increase their ability to excel, use cutting-edge science to develop the best nutritional supplements on the market, and provide a safe option for athletes.

MusclePharm's products were developed through exhaustive research at the MusclePharm Sports Science Center Research Institute. New products are created through a six-stage research protocol that involves the expertise of top nutritional scientists. Before launching a product, the company conducts field testing using a pool of over one hundred elite professional athletes from various professional sports leagues, including the National Football League, Mixed Martial Arts, and Major League Baseball.

Over the last few years, the consumption of sports nutrition products has shifted to mainstream consumers who have become the key drivers of growth within the industry. Teenagers and college students, women, and even older individuals are now using these products to help them live a more active and healthier lifestyle. With a full line of supplements and an extensive distribution network, MusclePharm is well positioned to capitalize on the growing demand. Disclaimer

MusclePharm Corp. Company Blog

MusclePharm Corp. News:

United States Sports Academy Researchers Present Clinical Trial Results For MusclePharms' Assault™ Pre-Workout

MusclePharm Announces Board Changes, Expansion

MusclePharm Nominated For 18 Bodybuilding.com Supplement Awards

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.26, even for the day, on 36,764 volume with 12 trades. The stock’s average daily volume over the past 60 days is 39,746, and its 52-week low/high is $0.21/$1.00.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corp to Present at the Southern California Investor Conference on August 30, 2012

SmallCapVoice Announces a New Audio Interview With Dr. Simon Craw, Executive Vice President of International Stem Cell Corporation

International Stem Cell Corp Announces World-Renowned Scientists Join as Advisors on Parkinson's Disease Program

Big Buyers Testify to the Future of Skinny Nutritional Corp. (SKNY)

If you sell retail consumer products, with the emphasis on physical stores versus online sales, one of your continuing concerns is going to be about shelf-space. The best product in the world won’t sell without adequate exposure, and that means convincing enough stores to give up some of their treasured shelf space to display your product. In the case of retail beverages, the competition is intense. Shelf space is at a premium, and a store’s retail buyer needs to know that your product has all the right things going for it in order to sell. The more product they can profitably move, the healthier their bottom line. Retail buyers live and die based on a thorough knowledge of their customer market, and a store won’t buy what it doesn’t think will move.

In the case of Skinny Nutritional, makers of Skinny Water brand health water drinks, the getting has been good, and its success is one of the strongest indications that the product is perceived as matching the market. The company sells a unique line of exclusive 100% naturally flavored waters containing zero-sugar, zero-carbs, zero calories, and zero sodium, together with customized blends of nutrients and electrolytes formulated for consumers focused on both health and taste.

Skinny has expanded rapidly to over 15,000 retail locations around the country, including big block chains like Target and CVS. Retail giants such as Target spend enormous amounts of time and money ensuring that the products they display have a future, and they clearly feel that Skinny Water falls in that category. In addition, Skinny Nutritional is also gearing up for possible moves into the snacks and meals category. In Skinny’s own words, they have a distinct brand that resonates with consumers.

For additional information, visit the company’s websites at: www.SkinnyWater.com

Daegis, Inc. (DAEG) Announces Key Enhancements to eDiscovery Platform

Daegis, a prominent provider of eDiscovery solutions, announced that it has made significant enhancements to the Daegis eDiscovery Platform. The improvements will offer more control of the eDiscovery process to users, provide enhanced search functionality, as well as add the ability to ingest and export data. This combination allows for superior flexibility in data management across the Electronic Discovery Reference Model (EDRM).

Data from IBM indicates that an incredible 2.5 quintillion (2.5 x 1018) bytes of data will be created every single day in 2012. This astounding expansion of electronically stored information from a multitude of sources, including email, social media, and mobile data, has caused eDiscovery practices to transition from a matter-by-matter to a data-driven approach requiring new technologies such as Daegis’ Cross-Matter Management methodology and innovative Master Repository. Daegis’ data driven approach will be become even more efficient and powerful as a result of the combination of new self-service methods for ingestion and export and bolstered search capabilities.

“As the volume and variety of data continue to escalate exponentially, attorneys are attempting to control costs by moving away from reinventing the wheel for each case with traditional, reactive, matter-specific eDiscovery,” said David Horrigan, eDiscovery and Information Governance analyst at 451 Research. “Corporate legal departments are embracing cost-cutting, data-driven models to analyze and manage data proactively across multiple matters rather than starting from scratch for each new case. This type of legal business model–and the platforms able to support it–will improve consistency both in search results and attorney review calls, thus delivering more defensible and affordable eDiscovery.”

Features of the Daegis eDiscovery Platform increasing user control include:

• Ingestion: The new self-ingestion feature allows clients to assemble data themselves and immediately upload batches of data directly to Daegis’ eDiscovery Platform via any internet connection. This new approach provides full transparency and security over the uploading of data while giving users the flexibility to immediately upload data needed for a project or a new matter.

• Export: Self-export enables users to export data from the platform to review small portions of a larger data set, create a discrete set of documents for expert witnesses, generate reports, and to transfer data to a separate location for further analysis. The introduction of new user-managed export tools allows clients to locate and process case materials for export and productions themselves.

• Iterative Search: Allows users to refine and validate a set of search criteria multiple times, making changes each time until an acceptable rate of responsive results are returned. The iterative search process adds tracking, reporting, and measurability to allow clients to target the most relevant document set for review while returning as few over and under inclusive results as possible. Changes to search criteria are recorded and saved to aid in the audit and defensibility of the search should it ever come into question.

• Enhanced Export for Lotus Notes Email: Enables users to export native Lotus Notes (NSF) email in expanded formats of EML, MSG, HTML, or TXT. Clients with Lotus Notes data can search and review documents leveraging the complete fidelity of native Lotus Notes, as well as export or produce those documents in different formats to meet the requirements of other parties or third party tools.

• CaseMap Integration: Daegis also offers powerful and flexible CaseMap integration, allowing clients to leverage information in Daegis’ eDiscovery Platform for their case organization and analysis.

“It is rewarding to see industry recognition of data-driven eDiscovery, as Daegis has long been a front-runner in both the vision of that approach and the execution of it through our technology platform,” said Deborah Jillson, President of Daegis. “The new features we’ve included in our software go a long way towards helping legal teams improve workflow and achieve even greater cost savings and control of what can be a very time-intensive and costly business process.”

For more information, please visit: www.daegis.com

Neuralstem, Inc. (CUR) Announces Completion of Initial NSI-566 Injections

Neuralstem, a biopharmaceutical company, continues its work on a cure for ALS, amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease. Beginning in January, 2010, Neuralstem has been transplanting its NSI-566 spinal cord neural stem cells into patients that can and cannot walk, Phase I of its NSI-566 testing. The Phase I testing was designed to inject the sample cells into 18 patients and has taken place at the Emory ALS Center in Atlanta. The principal investigator in the trial is Eva Feldman, MD, PhD, Director of the A. Alfred Taubman Medical Research Institute and Director of Research of the ALS Clinic at the University of Michigan Health System.

Yesterday, Neuralstem reached another milestone in its Phase I testing. Neuralstem announced it had injected the NSI-566 cells into the 18th patient. The eighteenth patient is the third to return to the trial for an additional set of injections. This patient is also the final patient in the Phase I portion of the trial as it is currently designed. The Phase I portion of the trial is scheduled to conclude six months after this final surgery.

Asked to comment, Karl Johe, PhD, Chairman of Neuralstem’s Board of Directors and Chief Scientific Officer said, “We are delighted to have completed Phase I in this groundbreaking trial, the first approved by the FDA to test neural stem cells in patients with ALS.”

“There have been many firsts in this trial, including the first lumbar intraspinal injections, the first cervical region intraspinal injections, and the first cohort of patients to receive both,” stated Jonathan D. Glass, MD, Director of the Emory ALS Center. “This has required incredible effort from the Emory medical and support team and I wish to express my thanks to all of them, as well as to acknowledge the generosity and courage of the patients and their families.”

Dr. Feldman, an unpaid consultant to Neuralstem, added,”[w]e have found the procedure to be extremely safe.” She continued, “In some patients, it appears that the disease is no longer progressing, but it is too early to know if the result from that small number of patients is meaningful.”

After testing via lower spine injections, the trial advanced to transplantation in the cervical (upper back) region of the spine. The first cohort of three was treated in the cervical region only. The last cohort of three received injections in both the cervical and lumbar regions of the spinal cord. In an amendment to the trial design, The Food and Drug Administration (FDA) approved the return of previously treated patients to this cohort. The entire 18-patient trial is set to conclude six months after the final surgery.

Neuralstem’s patented technology gives it the power to produce neural stem cells of the human brain and spinal cord in commercial quantities. Neuralstem has the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia, which are supportive cells in the central nervous system.

The company is also focusing on major central nervous system conditions with its cell therapy platform. Neuralstem is looking to cure spinal cord injury, ischemic spastic paraplegia, and chronic stroke. In fact, the company has submitted an IND (Investigational New Drug) application to the FDA for a Phase I safety trial in chronic spinal cord injury.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain’s capacity to generate new neurons. If the brain has the capacity to generate new neurons, this could potentially reverse the pathologies of some central nervous system conditions.

The company is in a Phase Ib safety trial evaluating NSI-189, its first neurogenic small molecule compound, for the treatment of major depressive disorder (MDD). NSI-189 might also be effective in treating chronic traumatic encephalopathy (CTE), Alzheimer’s disease, and post-traumatic stress disorder (PTSD).

Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.

Universal Bioenergy, Inc. (UBRG) A Growing Full-Spectrum Domestic Energy Producer with Strong Hand in Natural Gas and Coal

Universal Bioenergy, Inc. (OTCQB: UBRG) is a diversified, primarily hydrocarbon energy developer based in Irvine, CA, with an focus on aggressively pursuing natural gas, coal, oil, and alternative energy sources that will help facilitate its goal to be one of the top vertically integrated independent energy companies in the U.S.

Universal’s 49%-owned subsidiary, NDR Energy Group LLC (Charlotte, NC), is the primary natural gas operating unit and sold over 1.7B cubic feet of natural gas this August alone, pumping the stuff straight into the national energy supply via 29 of our largest domestic utility, electric power production, and even local gas distribution companies. Given the nature of the extremely soft gas market in 2012, the 22 signed contracts with major domestic utility companies like CenterPoint Energy Resources, Pacific Gas & Electric, and the Southern California Gas Company to name a few, went a long ways towards improving shareholder value.

That volume of gas sold under such market conditions is rather exceptional, representing a roughly 47% jump over the prior year’s figures for August. Already booked and sold, the natural gas sold from August alone will generate millions in sales revenues for the company. NDR is a full service seller and marketer of natural gas and has a complete suite of ancillary product capabilities in propane (HD-5), as well as other refined petroleum products. NDR even specializes in providing energy efficient lighting systems, as well as sustainable, alternative, and renewable class energy solutions designed for carbon footprint reduction. To this end NDR is also a major provider of energy management services, working directly with clientele to devise a highly-adapted, custom energy solution that is right for them.

A similar proficiency in coal was recently demonstrated by the initial revenues generated at UBRG’s Whitesburg Friday Branch Mine, down in Whitesburg, KY. The Whitesburg facility is churning out the perfect type of thermal/steam non-coking resource ideal for coal fired power plants. With some 3M tons of recoverable coal under contract (Elkhorn No. 3 Seam), the company is looking at a projected $52.80M in revenues and $5-8M in earnings annually. Whitesburg is just one example of the vast domestic coal production potential available and UBRG’s ability to sew up the challenging logistical/profit-taking end of the coal game puts shareholders in the ROI zone as the company moves to secure a larger production footprint. With U.S. EIA (Energy Information Administration) data projecting a 25% increase by 2035 for coal as an electricity source, we see a clear continued dominance of coal, with output rising from the current level nearly 38% to some 11k terawatt hours, an extremely promising long-term landscape for UBRG’s coal efforts.

Whitesburg has opened up augering in two segments already (with a third bonded and ready for augering) and the mining plan projects a dual auger unit configuration in order to meet mining forecast tonnage quantities. We are talking an estimated $264M in revenues over the next five years of development, and the company is currently in negotiations to acquire adjacent acreage. The objective here would be to ultimately secure a revised high wall mining Permit (anticipated for November) and the retaining of a high wall mining contractor to really take mine output to the next level. Already generating revenues in Q2 2012, the Whitesburg property is on schedule for Q4 earnings, led by hot summer months requiring substantial amounts of energy output from the nation’s grid.

Having reorganized structurally towards the goal of achieving a dominant market position in only 2010, a strong sector M&A strategy has led to a considerable foothold in a very short time for UBRG, with targets across the hydrocarbon and alternative energy spectrum all fair game.

The final current piece of the UBRG puzzle is the Georgia-based Texas Gulf Oil & Gas Inc. division created to develop, via JV, various domestic oil and natural gas opportunities, ultimately resulting in optimal natural gas and oil purchases from the wellhead. This division is also set up to handle the transmission and marketing of purchased fuels for dovetailing into the vertically integrated UBRG energy pipeline. The December 2010 agreement with ProGas Energy Services Inc. to JV with the company’s Texas Gulf subsidiary set the stage for this vector in the Premont Northwest oil and gas field.

With a full-court press on energy resource targets from across the spectrum, UBRG is dead set on carving out a dominant role for itself in the domestic energy game.

For more information on Universal Bioenergy Inc., please visit the company’s website at: www.UniversalBioEnergy.com

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Wallstreetlivechat
(AWWI)

2.

PennyTrader Publisher
(REVO)

3.

SmallCapVoice
(OCFN)

graphic
By The Numbers Charts
QualitystockTwits

Featured Sponsor

Daily Sponsors
















The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251